Early-onset cognitive deficits and axonal transport dysfunction in P301S mutant tau transgenic mice

Neuroscience Research

Volumn 80, Issue 1, 2014, Pages 76-85

  Onishi, Tomohiro ^a   Matsumoto, Yoshio ^a   Hattori, Masahiko ^a   Obayashi, Yuka ^a   Nakamura, Kimie ^a   Yano, Takashi ^a   Horiguchi, Takashi ^a   Iwashita, Hiroki ^a  

^a TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

Author keywords

Alzheimer's disease; Axonal transport; Frontotemporal lobar degeneration; Neurofibrillary tangles; Tau; Tg mouse model

Indexed keywords

NERVE PROTEIN; PROLINE; SERINE; TAU PROTEIN;

AGE; ANIMAL; COGNITIVE DEFECT; DISEASE COURSE; EXPLORATORY BEHAVIOR; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MAZE TEST; METABOLISM; MOTOR ACTIVITY; MOUSE; MUTATION; NERVE FIBER TRANSPORT; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; RECOGNITION; TRANSGENIC MOUSE;

AGE FACTORS; ANIMALS; AXONAL TRANSPORT; COGNITION DISORDERS; DISEASE PROGRESSION; EXPLORATORY BEHAVIOR; GENE EXPRESSION REGULATION; HUMANS; MAZE LEARNING; MICE; MICE, TRANSGENIC; MOTOR ACTIVITY; MUTATION; NERVE TISSUE PROTEINS; PHOSPHORYLATION; PROLINE; RECOGNITION (PSYCHOLOGY); SERINE; TAU PROTEINS;

EID: 84898833069     PISSN: 01680102     EISSN: 18728111     Source Type: Journal    
DOI: 10.1016/j.neures.2013.12.006     Document Type: Article

References (49)

1. Allen B., Ingram E., Takao M., Smith M.J., Jakes R., Virdee K., Yoshida H., Holzer M., Craxton M., Emson P.C., Atzori C., Migheli A., Crowther R.A., Ghetti B., Spillantini M.G., Goedert M. Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein. J. Neurosci. 2002, 22:9340-9351.
2. Barten D.M., Fanara P., Andorfer C., Hoque N., Wong P.Y., Husted K.H., Cadelina G.W., Decarr L.B., Yang L., Liu V., Fessler C., Protassio J., Riff T., Turner H., Janus C.G., Sankaranarayanan S., Polson C., Meredith J.E., Gray G., Hanna A., Olson R.E., Kim S.H., Vite G.D., Lee F.Y., Albright C.F. Hyperdynamic microtubules, cognitive deficits, and pathology are improved in tau transgenic mice with low doses of the microtubule-stabilizing agent BMS-241027. J. Neurosci. 2012, 32:7137-7145.
3. Belarbi K., Schindowski K., Burnouf S., Caillierez R., Grosjean M.E., Demeyer D., Hamdane M., Sergeant N., Blum D., Buée L. Early tau pathology involving the septo-hippocampal pathway in a tau transgenic model: relevance to Alzheimer's disease. Curr. Alzheimer Res. 2009, 6:152-157.
4. Belarbi K., Burnouf S., Fernandez-Gomez F.J., Desmercières J., Troquier L., Brouillette J., Tsambou L., Grosjean M.E., Caillierez R., Demeyer D., Hamdane M., Schindowski K., Blum D., Buée L. Loss of medial septum cholinergic neurons in THY-Tau22 mouse model: what links with tau pathology?. Curr. Alzheimer Res. 2011, 8:633-638.
5. Bellucci A., Luccarini I., Scali C., Prosperi C., Giovannini M.G., Pepeu G., Casamenti F. Cholinergic dysfunction, neuronal damage and axonal loss in TgCRND8 mice. Neurobiol. Dis. 2006, 23:260-272.
6. Black M.M., Baas P.W., Humphries S. Dynamics of alpha-tubulin deacetylation in intact neurons. J. Neurosci. 1989, 9:358-368.
7. Brunden K.R., Zhang B., Carroll J., Yao Y., Potuzak J.S., Hogan A.M., Iba M., James M.J., Xie S., Ballatore C., Smith A.B., Lee V.M., Trojanowski J.Q. Epothilone D improves microtubule density, axonal integrity, and cognition in a transgenic mouse model of tauopathy. J. Neurosci. 2010, 30:13861-13866.
8. Bugiani O., Murrell J.R., Giaccone G., Hasegawa M., Ghigo S., Tabaton M., Morbin M., Primavera A., Carella F., Solaro C., Grisoli M., Savoiardo M., Spillantini M.G., Tagliavini F., Goedert M., Ghetti B. Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau. J. Neuropathol. Exp. Neurol. 1999, 58:667-677.
9. Dixit R., Ross J.L., Goldman Y.E., Holzbaur E.L. Differential regulation of dynein and kinesin motor proteins by tau. Science 2008, 319:1086-1089.
10. Drechsel D.N., Hyman A.A., Cobb M.H., Kirschner M.W. Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau. Mol. Biol. Cell. 1992, 3:1141-1154.
11. Eckermann K., Mocanu M.M., Khlistunova I., Biernat J., Nissen A., Hofmann A., Schönig K., Bujard H., Haemisch A., Mandelkow E., Zhou L., Rune G., Mandelkow E.M. The beta-propensity of tau determines aggregation and synaptic loss in inducible mouse models of tauopathy. J. Biol. Chem. 2007, 282:31755-31765.
12. Fanara P., Banerjee J., Hueck R.V., Harper M.R., Awada M., Turner H., Husted K.H., Brandt R., Hellerstein M.K. Stabilization of hyperdynamic microtubules is neuroprotective in amyotrophic lateral sclerosis. J. Biol. Chem. 2007, 282:23465-23472.
13. Fanara P., Husted K.H., Selle K., Wong P.Y., Banerjee J., Brandt R., Hellerstein M.K. Changes in microtubule turnover accompany synaptic plasticity and memory formation in response to contextual fear conditioning in mice. Neuroscience 2010, 168:167-178.
14. Fanara P., Wong P.Y., Husted K.H., Liu S., Liu V.M., Kohlstaedt L.A., Riiff T., Protasio J.C., Boban D., Killion S., Killian M., Epling L., Sinclair E., Peterson J., Price R.W., Cabin D.E., Nussbaum R.L., Brühmann J., Brandt R., Christine C.W., Aminoff M.J., Hellerstein M.K. Cerebrospinal fluid-based kinetic biomarkers of axonal transport in monitoring neurodegeneration. J. Clin. Invest. 2012, 122:3159-3169.
15. Flunkert S., Hierzer M., Löffler T., Rabl R., Neddens J., Duller S., Schofield E.L., Ward M.A., Posch M., Jungwirth H., Windisch M., Hutter-Paier B. Elevated levels of soluble total and hyperphosphorylated tau result in early behavioral deficits and distinct changes in brain pathology in a new tau transgenic mouse model. Neurodegener. Dis. 2013, 11:194-205.
16. Friedhoff P., von Bergen M., Mandelkow E.M., Mandelkow E. Structure of tau protein and assembly into paired helical filaments. Biochim. Biophys. Acta 2000, 1502:122-132.
17. Goedert M., Wischikm C.M., Crowther R.A., Walker J.E., Klug A. Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau. Proc. Natl. Acad. Sci. U. S. A. 1988, 85:4051-4055.
18. Goedert M., Spillantini M.G., Jakes R., Crowther R.A., Vanmechelen E., Probst A., Götz J., Bürki K., Cohen P. Molecular dissection of the paired helical filament. Neurobiol. Aging 1995, 16:325-334.
19. Goedert M., Jakes R., Crowther R.A. Effects of frontotemporal dementia FTDP-17 mutations on heparin-induced assembly of tau filaments. FEBS. Lett. 1999, 450:306-311.
20. Götz J., Ittner L.M. Animal models of Alzheimer's disease and frontotemporal dementia. Nat. Rev. Neurosci. 2008, 9:532-544.
21. Grundke-Iqbal I., Iqbal K., Tung Y.C., Quinlan M., Wisniewski H.M., Binder L.I. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. U. S. A. 1986, 83:4913-4917.
22. Henthorn K.S., Roux M.S., Herrera C., Goldstein L.S. A role for kinesin heavy chain in controlling vesicle transport into dendrites in Drosophila. Mol. Biol. Cell 2011, 22:4038-4046.
23. Hurd D.D., Saxton W.M. Kinesin mutations cause motor neuron disease phenotypes by disrupting fast axonal transport in Drosophila. Genetics 1996, 144:1075-1085.
24. Hutton M., Lendon C.L., Rizzu P., Baker M., Froelich S., Houlden H., Pickering-Brown S., Chakraverty S., Isaacs A., Grover A., Hackett J., Adamson J., Lincoln S., Dickson D., Davies P., Petersen R.C., Stevens M., de Graaff E., Wauters E., van Baren J., Hillebrand M., Joosse M., Kwon J.M., Nowotny P., Che L.K., Norton J., Morris J.C., Reed L.A., Trojanowski J., Basun H., Lannfelt L., Neystat M., Fahn S., Dark F., Tannenberg T., Dodd P.R., Hayward N., Kwok J.B., Schofield P.R., Andreadis A., Snowden J., Craufurd D., Neary D., Owen F., Oostra B.A., Hardy J., Goate A., van Swieten J., Mann D., Lynch T., Heutink P. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998, 393:702-705.
25. Iritani S., Niizato K., Emson P.C. Relationship of calbindin D28K-immunoreactive cells and neuropathological changes in the hippocampal formation of Alzheimer's disease. Neuropathology 2001, 21:162-167.
26. Ishihara T., Hong M., Zhang B., Nakagawa Y., Lee M.K., Trojanowski J.Q., Lee V.M. Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform. Neuron 1999, 3:751-762.
27. Ishihara T., Zhang B., Higuchi M., Yoshiyama Y., Trojanowski J.Q., Lee V.M. Age-dependent induction of congophilic neurofibrillary tau inclusions in tau transgenic mice. Am. J. Pathol. 2001, 158:555-562.
28. Ittner L.M., Fath T., Ke Y.D., Bi M., van Eersel J., Li K.M., Gunning P., Götz J. Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementia. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:15997-16002.
29. Lee G., Cowan N., Kirschner M. The primary structure and heterogeneity of tau protein from mouse brain. Science 1998, 239:285-288.
30. Lee V.M., Goedert M., Trojanowski J.Q. Neurodegenerative tauopathies. Annu. Rev. Neurosci. 2001, 24:1121-1159.
31. Lewis J., McGowan E., Rockwood J., Melrose H., Nacharaju P., Van Slegtenhorst M., Gwinn-Hardy K., Paul Murphy M., Baker M., Yu X., Duff K., Hardy J., Corral A., Lin W.L., Yen S.H., Dickson D.W., Davies P., Hutton M. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat. Genet. 2000, 25:402-405.
32. Lossos A., Reches A., Gal A., Newman J.P., Soffer D., Gomori J.M., Boher M., Ekstein D., Biran I., Meiner Z., Abramsky O., Rosenmann H. Frontotemporal dementia and parkinsonism with the P301S tau gene mutation in a Jewish family. J. Neurol. 2003, 250:733-740.
33. Onishi T., Iwashita H., Uno Y., Kunitomo J., Saitoh M., Kimura E., Fujita H., Uchiyama N., Kori M., Takizawa M. A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S)-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease. J. Neurochem. 2011, 119:1330-1340.
34. Poorkaj P., Bird T.D., Wijsman E., Nemens E., Garruto R.M., Anderson L., Andreadis A., Wiederholt W.C., Raskind M., Schellenberg G.D. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann. Neurol. 1998, 43:815-825.
35. Riascos D., de Leon D., Baker-Nigh A., Nicholas A., Yukhananov R., Bu J., Wu C.K., Geula C. Age-related loss of calcium buffering and selective neuronal vulnerability in Alzheimer's disease. Acta Neuropathol. 2011, 122:565-576.
36. Sahara N., Vega I.E., Ishizawa T., Lewis J., McGowan E., Hutton M., Dickson D., Yen S.H. Phosphorylated p38MAPK specific antibodies cross-react with sarkosyl-insoluble hyperphosphorylated tau proteins. J. Neurochem. 2004, 90:829-838.
37. SantaCruz K., Lewis J., Spires T., Paulson J., Kotilinek L., Ingelsson M., Guimaraes A., DeTure M., Ramsden M., McGowan E., Forster C., Yue M., Orne J., Janus C., Mariash A., Kuskowski M., Hyman B., Hutton M., Ashe K.H. Tau suppression in a neurodegenerative mouse model improves memory function. Science 2005, 309:476-481.
38. Spillantini M.G., Murrell J.R., Goedert M., Farlow M.R., Klug A., Ghetti B. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:7737-7741.
39. Stokin G.B., Lillo C., Falzone T.L., Brusch R.G., Rockenstein E., Mount S.L., Raman R., Davies P., Masliah E., Williams D.S., Goldstein L.S. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 2005, 307:1282-1288.
40. Takeuchi H., Iba M., Inoue H., Higuchi M., Takao K., Tsukita K., Karatsu Y., Iwamoto Y., Miyakawa T., Suhara T., Trojanowski J.Q., Lee V.M., Takahashi R. P301S mutant human tau transgenic mice manifest early symptoms of human tauopathies with dementia and altered sensorimotor gating. PLoS ONE 2011, 6:e21050.
41. Taniguchi S., Suzuki N., Masuda M., Hisanaga S., Iwatsubo T., Goedert M., Hasegawa M. Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins. J. Biol. Chem. 2005, 280:7614-7623.
42. Uno Y., Iwashita H., Tsukamoto T., Uchiyama N., Kawamoto T., Kori M., Nakanishi A. Efficacy of a novel, orally active GSK-3 inhibitor 6-methyl-N-[3-[[3-(1-methylethoxy)propyl]carbamoyl]-1H-pyrazol-4-yl]pyridine-3-carboxamide in tau transgenic mice. Brain Res. 2009, 3:148-163.
43. Werber E., Klein C., Grünfeld J., Rabey J.M. Phenotypic presentation of frontotemporal dementia with Parkinsonism-chromosome 17 type P301S in a patient of Jewish-Algerian origin. Mov. Disord. 2003, 18:595-598.
44. Wittmann C.W., Wszolek M.F., Shulman J.M., Salvaterra P.M., Lewis J., Hutton M., Feany M.B. Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science 2001, 293:711-714.
45. Yasuda M., Yokoyama K., Nakayasu T., Nishimura Y., Matsui M., Yokoyama T., Miyoshi K., Tanaka C. A Japanese patient with frontotemporal dementia and parkinsonism by a tau P301S mutation. Neurology 2000, 55:1224-1227.
46. Yoshiyama Y., Higuchi M., Zhang B., Huang S.M., Iwata N., Saido T.C., Maeda J., Suhara T., Trojanowski J.Q., Lee V.M. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 2007, 53:337-351.
47. Zhang B., Higuchi M., Yoshiyama Y., Ishihara T., Forman M.S., Martinez D., Joyce S., Trojanowski J.Q., Lee V.M. Retarded axonal transport of R406W mutant tau in transgenic mice with a neurodegenerative tauopathy. J. Neurosci. 2004, 24:4657-4667.
48. Zhang B., Maiti A., Shively S., Lakhani F., McDonald-Jones G., Bruce J., Lee E.B., Xie S.X., Joyce S., Li C., Toleikis P.M., Lee V.M., Trojanowski J.Q. Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:227-231.
49. Zhang B., Carroll J., Trojanowski J.Q., Yao Y., Iba M., Potuzak J.S., Hogan A.M., Xie S.X., Ballatore C., Smith A.B., Lee V.M., Brunden K.R. The microtubule-stabilizing agent, epothilone D, reduces axonal dysfunction, neurotoxicity, cognitive deficits, and Alzheimer-like pathology in an interventional study with aged tau transgenic mice. J. Neurosci. 2012, 32:3601-3611.